Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 6Sarcoma 5Sarcoma, Ewing 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, B-Cell 2Teratoma 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Perivascular Epithelioid Cell Neoplasms 1Osteosarcoma 1Nonseminomatous germ cell tumor 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Liposarcoma 1Leukemia, Biphenotypic, Acute 1Leiomyosarcoma 1Ichthyosis, X-Linked 1Hodgkin Disease 1

Interventions

Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Melphalan 2Etoposide 2Cyclophosphamide 2Busulfan 2venetoclax 1selinexor 1fludarabine phosphate 1fludarabine 1Triamcinolone 1Sirolimus 1Rituximab 1Receptors, Chimeric Antigen 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Cyclosporine 1Carboplatin 1Automobiles 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Dendritic Cell Sarcoma, Interdigitating × Ifosfamide × Clear all
NCT03064867 2022-11-16

Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Case Comprehensive Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡